A novel human leucine-rich repeat containing protein expressed predominately in bone marrow. HLRRBM1

Details for Australian Patent Application No. 2002245162 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Ramanathan, Chandra; Feder, John; Mintier, Gabe

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002245162

PCT Pub. Number WO2002/052011

Priority 60/257,773 22.12.00 US

Filing date 20 December 2001

Wipo publication date 8 July 2002

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C07K 014/47 Peptides having more than 20 amino acids

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 038/17 Medicinal preparations containing peptides - from animals

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002245162

20 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245163-CONTROLLED DOSE DELIVERY OF ULTRAVIOLET LIGHT FOR TREATING SKIN DISORDERS

2002245161